Results 161 to 170 of about 6,714 (194)
P456: Novel UBA1 variant associated with attenuated X-linked SMA phenotype
Sofia Jares Baglivo +2 more
openaire +2 more sources
VEXAS Syndrome: Genetics, Gender Differences, Clinical Insights, Diagnostic Pitfalls, and Emerging Therapies. [PDF]
Corrao S +8 more
europepmc +1 more source
A cross-sectional survey on VEXAS syndrome: insights from a global expert panel. [PDF]
Ali SB, Gurnari C.
europepmc +1 more source
Clinical features in VEXAS syndrome: a systematic review. [PDF]
Al-Hakim A +5 more
europepmc +1 more source
Identification of post-translational modification-related biomarkers in ischemic stroke using bioinformatics and machine learning. [PDF]
Bian X +5 more
europepmc +1 more source
Is immunotherapy safe and effective in patients with VEXAS syndrome? [PDF]
Marvisi C +9 more
europepmc +1 more source
A rare case of VEXAS syndrome. [PDF]
Gupta K, El-Ghazali S, Kubba F.
europepmc +1 more source
UBA1: At the Crossroads of Ubiquitin Homeostasis and Neurodegeneration [PDF]
Neurodegenerative diseases are a leading cause of disability and early death. A common feature of these conditions is disruption of protein homeostasis. Ubiquitin-like modifier activating enzyme 1 (UBA1), the E1 ubiquitin-activating enzyme, sits at the apex of the ubiquitin cascade and represents an important regulator of cellular protein homeostasis ...
Ewout J N Groen, Thomas Gillingwater
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Three UBA1 clones for a unique VEXAS syndrome
Rheumatology, 2023Dear Editor, The VEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) is a recently described autoinflammatory disease characterized by mutations in the E1 ubiquitin-activating enzyme encoded by the UBA1 gene [1]. Clinico-biological findings include haematological abnormalities, treatment-refractory inflammatory syndrome, skin ...
Podvin, Benjamin +7 more
openaire +2 more sources

